Clinical trial
A Phase 1 Non-Randomized Open Label Study of ICM20
NCT05523596 is registered in ClinicalTrials.gov with IC-MedTech Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Non-Randomized Open Label Study of ICM20
- Lead sponsor
- IC-MedTech Corporation
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 20, 2023
- Completion date
- October 3, 2025
- Enrollment
- 13 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
safety issues